Evidence map›Paper›PMID 40172737›Full record

Observational studyCerebellum (London, England)2025

CSF Markers of TG6 Autoimmunity in Gluten Ataxia.

Mara-Luciana Floare, Stephen B Wharton, Julie E Simpson, Daniel Aeschlimann, Marios Hadjivassiliou

Abstract readObservational Study
In one paragraph

Observational study in Cerebellum (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mara-Luciana FloareSheffield Institute for Translational Neuroscience, The University of Sheffield, Sheffield, UK. m.l.floare@sheffield.ac.uk.
Stephen B WhartonSheffield Institute for Translational Neuroscience, The University of Sheffield, Sheffield, UK.
Julie E SimpsonSheffield Institute for Translational Neuroscience, The University of Sheffield, Sheffield, UK.
Daniel AeschlimannMatrix Biology & Tissue Repair Research Unit, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK.
Marios HadjivassiliouAcademic Departments of Neurosciences and Neuroradiology, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gluten ataxia (GA) is the primary neurological manifestation of gluten sensitivity, characterised by loss of Purkinje cells throughout the cerebellar cortex and rooted in autoimmunity to transglutaminase 6 (TG6). Previous studies have shown the contribution of serum anti-TG6 antibodies to disease progression; however, it remains unclear where these antibodies are produced and how they gain access into the brain parenchyma. This study aims to provide an immunological assessment of the CSF in patients with GA to better define the humoral response contributing to disease pathophysiology. In this observational study we assessed the presence of plasma cells in the CSF of 20 patients with GA and 6 controls. CSF from 16 of the GA patients and from all 6 controls was investigated for the presence of anti-TG6 IgA antibodies. Immunohistochemistry for CD138 was performed to assess the presence of plasma cells in the cerebellum and spinal cord of 4 cases with GA, 4 ataxia controls and 4 neurologically healthy controls. A significant increase in anti-TG6 IgA antibodies was detected in the CSF of patients with GA compared to controls, with no correlation between CSF and serum levels of anti-TG6 IgA antibodies for either experimental group. CD138

Indexed as

AtaxiaAutoantibodiesAutoimmunityTransglutaminasesAdultAgedBiomarkersCerebellumFemaleGlutensHumansImmunoglobulin AMaleMiddle AgedPlasma CellsSpinal CordAutoantibodiesBiomarkersGlutensImmunoglobulin ASDC1 protein, humanSyndecan-1TGM6 protein, humanTransglutaminasesAtaxiaNeuroinflammationPlasma cellsTransglutaminase

Identifiers

PMID40172737
PMCPMC11965251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.